AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimidart M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Oswin Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimidart M 2mg/500mg Tablet SR

Diabetic patients often utilize the combined medication, Glimidart M 2mg/500mg SR tablets, an anti-diabetic agent. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan, encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, or tremors. Be prepared to treat hypoglycemia with readily available glucose sources like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections; weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is essential, and your physician may order blood tests to assess blood cell counts and liver function.

Uses of Glimidart M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimidart M 2mg/500mg Tablet SR:

Follow your physician's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimidart M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Glimidart M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimidart M 2mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or dividing it. The Glimidart M 2mg/500mg Extended-Release tablet should be taken with a meal.

How Glimidart M 2mg/500mg Tablet SR works:

Glimidart M 2mg/500mg Extended-Release Tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts through a triple mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimidart M 2mg/500mg SR tablets with alcohol is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimidart M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimidart M tablets (2mg/500mg) are contraindicated during lactation due to the potential for infant harm from the medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimidart M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. Glimidart M 2mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimidart M 2mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. A reduced initial dose is typically recommended for patients exhibiting mild to moderate liver dysfunction; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Glimidart M 2mg/500mg Tablet SR :

Should you forget to take a Glimidart M 2mg/500mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimidart M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimidart M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimidart M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimidart M and seek immediate medical attention.
Glimidart M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimidart M 2mg/500mg SR Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Glimidart M 2mg/500mg SR tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 intake is recommended annually, as suggested by some researchers.
Glimidart M 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimidart M 2mg/500mg SR tablets with alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimidart M 2mg/500mg Tab...
53
MRP 65
18% off